AHS: Research Informs New Migraine Rx Guidelines

This article originally appeared here.
Share this content:
AHS: Research Informs New Migraine Rx Guidelines
AHS: Research Informs New Migraine Rx Guidelines

(HealthDay News) -- Researchers have reviewed recent scientific literature and concluded that a number of classes of drugs are effective for treating acute migraine. The study, published in the January issue of Headache, will form the basis of new American Headache Society guidelines for the treatment of migraine.

The medications include triptans, dihydroergotamine, and many nonsteroidal anti-inflammatory drugs, including aspirin, ibuprofen, and naproxen. Also on the list: butorphanol nasal spray, and the combination medications sumatriptan/naproxen and acetaminophen/aspirin/caffeine. Several other medications are "probably effective" or "possibly effective."

While opioids such as butorphanol, codeine/acetaminophen, and tramadol/acetaminophen are likely effective migraine treatments, they are not recommended for regular use, the researchers said.

"We hope that this assessment of the efficacy of currently available migraine therapies helps patients and their physicians utilize treatments that are the most appropriate for them," study coauthor Stephen Silberstein, M.D., said in an American Headache Society news release. He is a professor of neurology and director of the Jefferson Headache Center of Thomas Jefferson University in Philadelphia.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Some California Mosquitoes Can Carry Zika Virus

Some California Mosquitoes Can Carry Zika Virus

Aedes aegypti mosquitoes found to transmit Zika virus

Periodontal Inflammation a Risk With Tongue Piercing

Periodontal Inflammation a Risk With Tongue Piercing

And, two young females with tongue piercings have deep lingual infrabony lesions, periodontitis

Risk of OD Highest for First Days of Opioid  Benzodiazepine Use

Risk of OD Highest for First Days of ...

Five-fold increased risk of opioid-related overdose during first 90 days of concurrent use

is free, fast, and customized just for you!




Already a member?

Sign In Now »